Back

The FRAME-AMI trial - FFR vs. Angiography-guided PCI in AMI with multivessel disease

28 August 2022 (17:10 - 17:22)
Organised by:
Congress Presentation Part of: HOT LINE SESSION 7 Primary Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Joo-Yong Hahn

Samsung Medical Center, Seoul (Korea (Republic of))

8 More presentations in this session

Presentation thumbnail
DanNICAD-2 - Perfusion scanning with MR or PET after a positive CT coronary angiography.
Doctor M. Bottcher (Aarhus, DK)
Slides Video
Presentation thumbnail
Discussant review - Dan-NICAD-2 .
Professor C. Berry (Glasgow, GB)
Slides Video
Presentation thumbnail
Panel discussion - Dan-NICAD-2 .
Video
Presentation thumbnail
The PRE18FFIR Trial: Coronary Plaque Activity to Predict Recurrent Events.
Professor D. Newby (Edinburgh, GB)
Slides Video
Presentation thumbnail
Discussant review - The PRE18FFIR Trial
Associate Professor B. Raman (Oxford, GB)
Slides Video

Access the full session

Session thumbnail
HOT LINE SESSION 7
Video

The Event

Event poster

ESC Congress 2022

28 August 2022 17:10 CET
You may be interested in
thumbnail
Congress Presentation
Prognosis after non-infarct related artery PCI in patients with acute myocardial infarction and multivessel disease: substudy of FRAME-AMI trial
thumbnail
Congress Presentation
Differential outcomes in FFR-guided versus angiography-guided revascularization strategy according to target non-infarct related vessels: from FRAME-AMI trial
thumbnail
Congress Presentation
The role of physiological assessment of the non-culprit artery

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources